Literature DB >> 22498942

Validation of an algorithm for the diagnosis of serous tubal intraepithelial carcinoma.

Russell Vang1, Kala Visvanathan, Amy Gross, Emily Maambo, Mamta Gupta, Elisabetta Kuhn, Rose Fanghong Li, Brigitte M Ronnett, Jeffrey D Seidman, Anna Yemelyanova, Ie-Ming Shih, Patricia A Shaw, Robert A Soslow, Robert J Kurman.   

Abstract

It has been reported that the diagnosis of serous tubal intraepithelial carcinoma (STIC) is not optimally reproducible on the basis of only histologic assessment. Recently, we reported that the use of a diagnostic algorithm that combines histologic features and coordinate immunohistochemical expression of p53 and Ki-67 substantially improves reproducibility of the diagnosis. The goal of the current study was to validate this algorithm by testing a group of 6 gynecologic pathologists who had not participated in the development of the algorithm (3 faculty and 3 fellows) but who were trained in its use by referring to a website designed for the purpose. They then reviewed a set of microscopic slides, which contained 41 mucosal lesions of the fallopian tube. Overall consensus (≥4 of 6 pathologists) for the 4 categories of STIC, serous tubal intraepithelial lesion (our atypical intermediate category), p53 signature, and normal/reactive was achieved in 76% of the lesions, with no consensus in 24%. Combining diagnoses into 2 categories (STIC versus non-STIC) resulted in an overall consensus of 93% and no consensus in 7%. The κ value for STIC versus non-STIC among all 6 observers was also high at 0.67 and did not significantly differ, whether for faculty (κ=0.66) or fellows (κ=0.60). These findings confirm the reproducibility of this algorithm by a group of gynecologic pathologists who were trained on a website for that purpose. Accordingly, we recommend its use in research studies. Before applying it to routine clinical practice, the algorithm should be evaluated by general surgical pathologists in a community setting.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22498942      PMCID: PMC3366037          DOI: 10.1097/PGP.0b013e31823b8831

Source DB:  PubMed          Journal:  Int J Gynecol Pathol        ISSN: 0277-1691            Impact factor:   2.762


  28 in total

1.  A candidate precursor to serous carcinoma that originates in the distal fallopian tube.

Authors:  Y Lee; A Miron; R Drapkin; M R Nucci; F Medeiros; A Saleemuddin; J Garber; C Birch; H Mou; R W Gordon; D W Cramer; F D McKeon; C P Crum
Journal:  J Pathol       Date:  2007-01       Impact factor: 7.996

2.  Serous tubal intraepithelial carcinoma: diagnostic reproducibility and its implications.

Authors:  Joseph W Carlson; Elke A Jarboe; David Kindelberger; Marisa R Nucci; Michelle S Hirsch; Christopher P Crum
Journal:  Int J Gynecol Pathol       Date:  2010-07       Impact factor: 2.762

3.  Low prevalence of (pre) malignant lesions in the breast and high prevalence in the ovary and Fallopian tube in women at hereditary high risk of breast and ovarian cancer.

Authors:  Brenda B J Hermsen; Paul J van Diest; Johannes Berkhof; Fred H Menko; Johan J P Gille; Jurgen M J Piek; Sybren Meijer; Henri A H Winters; Peter Kenemans; Silvia von Mensdorff-Pouilly; René H M Verheijen
Journal:  Int J Cancer       Date:  2006-09-15       Impact factor: 7.396

4.  Serous carcinogenesis in the fallopian tube: a descriptive classification.

Authors:  Elke Jarboe; Ann Folkins; Marisa R Nucci; David Kindelberger; Ronny Drapkin; Alexander Miron; Yonghee Lee; Christopher P Crum
Journal:  Int J Gynecol Pathol       Date:  2008-01       Impact factor: 2.762

5.  Serous tubal intraepithelial carcinoma upregulates markers associated with high-grade serous carcinomas including Rsf-1 (HBXAP), cyclin E and fatty acid synthase.

Authors:  Ann Smith Sehdev; Robert J Kurman; Elisabetta Kuhn; Ie-Ming Shih
Journal:  Mod Pathol       Date:  2010-03-12       Impact factor: 7.842

6.  Utility of p16 expression for distinction of uterine serous carcinomas from endometrial endometrioid and endocervical adenocarcinomas: immunohistochemical analysis of 201 cases.

Authors:  Anna Yemelyanova; Hongxiu Ji; Ie-Ming Shih; Tian-Li Wang; Lee-Shu-Fune Wu; Brigitte M Ronnett
Journal:  Am J Surg Pathol       Date:  2009-10       Impact factor: 6.394

7.  HER-2/neu and p27Kip1 in progression of Fallopian tube carcinoma: an immunohistochemical and array comparative genomic hybridization study.

Authors:  M E Nowee; J C Dorsman; J M J Piek; V M Kosma; K Hämäläinen; R H M Verheijen; P J van Diest
Journal:  Histopathology       Date:  2007-11       Impact factor: 5.087

8.  Chromosomal instability in fallopian tube precursor lesions of serous carcinoma and frequent monoclonality of synchronous ovarian and fallopian tube mucosal serous carcinoma.

Authors:  Shannon Salvador; Allan Rempel; Robert A Soslow; Blake Gilks; David Huntsman; Dianne Miller
Journal:  Gynecol Oncol       Date:  2008-07-01       Impact factor: 5.482

9.  HMGA2: a potential biomarker complement to P53 for detection of early-stage high-grade papillary serous carcinoma in fallopian tubes.

Authors:  Jian-Jun Wei; Jingjing Wu; Chunyan Luan; Anjana Yeldandi; Peng Lee; Pacita Keh; Jinsong Liu
Journal:  Am J Surg Pathol       Date:  2010-01       Impact factor: 6.394

10.  Candidate serous cancer precursors in fallopian tube epithelium of BRCA1/2 mutation carriers.

Authors:  Patricia A Shaw; Marjan Rouzbahman; Ellen S Pizer; Melania Pintilie; Heather Begley
Journal:  Mod Pathol       Date:  2009-06-19       Impact factor: 7.842

View more
  37 in total

Review 1.  It's Totally Tubular....Riding The New Wave of Ovarian Cancer Research.

Authors:  Ruth Perets; Ronny Drapkin
Journal:  Cancer Res       Date:  2015-12-15       Impact factor: 12.701

2.  The diagnostic and biological implications of laminin expression in serous tubal intraepithelial carcinoma.

Authors:  Elisabetta Kuhn; Robert J Kurman; Robert A Soslow; Guangming Han; Ann Smith Sehdev; Patrick J Morin; Tian-Li Wang; Ie-Ming Shih
Journal:  Am J Surg Pathol       Date:  2012-12       Impact factor: 6.394

3.  Clinical outcome of isolated serous tubal intraepithelial carcinomas (STIC).

Authors:  Stephanie L Wethington; Kay J Park; Robert A Soslow; Noah D Kauff; Carol L Brown; Fanny Dao; Ebunoluwa Otegbeye; Yukio Sonoda; Nadeem R Abu-Rustum; Richard R Barakat; Douglas A Levine; Ginger J Gardner
Journal:  Int J Gynecol Cancer       Date:  2013-11       Impact factor: 3.437

4.  An Alternate Diagnostic Algorithm for the Diagnosis of Intraepithelial Fallopian Tube Lesions.

Authors:  Marie E Perrone; Nicholas P Reder; Sergay N Agoff; Rochelle L Garcia; Kathy J Agnew; Barbara M Norquist; Kathryn P Pennington; Elizabeth M Swisher; Mark R Kilgore
Journal:  Int J Gynecol Pathol       Date:  2020-05       Impact factor: 2.762

Review 5.  Rationale for Developing a Specimen Bank to Study the Pathogenesis of High-Grade Serous Carcinoma: A Review of the Evidence.

Authors:  Mark E Sherman; Ronny I Drapkin; Neil S Horowitz; Christopher P Crum; Sue Friedman; Janice S Kwon; Douglas A Levine; Ie-Ming Shih; Donna Shoupe; Elizabeth M Swisher; Joan Walker; Britton Trabert; Mark H Greene; Goli Samimi; Sarah M Temkin; Lori M Minasian
Journal:  Cancer Prev Res (Phila)       Date:  2016-05-24

6.  Analysis of Telomere Lengths in p53 Signatures and Incidental Serous Tubal Intraepithelial Carcinomas Without Concurrent Ovarian Cancer.

Authors:  Shiho Asaka; Christine Davis; Shiou-Fu Lin; Tian-Li Wang; Christopher M Heaphy; Ie-Ming Shih
Journal:  Am J Surg Pathol       Date:  2019-08       Impact factor: 6.394

7.  Long interspersed element-1 protein expression is a hallmark of many human cancers.

Authors:  Nemanja Rodić; Reema Sharma; Rajni Sharma; John Zampella; Lixin Dai; Martin S Taylor; Ralph H Hruban; Christine A Iacobuzio-Donahue; Anirban Maitra; Michael S Torbenson; Michael Goggins; Ie-Ming Shih; Amy S Duffield; Elizabeth A Montgomery; Edward Gabrielson; George J Netto; Tamara L Lotan; Angelo M De Marzo; William Westra; Zev A Binder; Brent A Orr; Gary L Gallia; Charles G Eberhart; Jef D Boeke; Chris R Harris; Kathleen H Burns
Journal:  Am J Pathol       Date:  2014-03-06       Impact factor: 4.307

8.  Long Interspersed Nuclear Element 1 Retrotransposons Become Deregulated during the Development of Ovarian Cancer Precursor Lesions.

Authors:  Thomas R Pisanic; Shiho Asaka; Shiou-Fu Lin; Ting-Tai Yen; Hanru Sun; Asli Bahadirli-Talbott; Tza-Huei Wang; Kathleen H Burns; Tian-Li Wang; Ie-Ming Shih
Journal:  Am J Pathol       Date:  2018-12-13       Impact factor: 4.307

9.  The conceptual advances of carcinogenic sequence model in high-grade serous ovarian cancer.

Authors:  Hiroshi Kobayashi; Kana Iwai; Emiko Niiro; Sachiko Morioka; Yuki Yamada; Kenji Ogawa; Naoki Kawahara
Journal:  Biomed Rep       Date:  2017-07-27

10.  Reported Incidence and Survival of Fallopian Tube Carcinomas: A Population-Based Analysis From the North American Association of Central Cancer Registries.

Authors:  Britton Trabert; Sally B Coburn; Andrea Mariani; Hannah P Yang; Philip S Rosenberg; Gretchen L Gierach; Nicolas Wentzensen; Kathy A Cronin; Mark E Sherman
Journal:  J Natl Cancer Inst       Date:  2018-07-01       Impact factor: 13.506

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.